Page last updated: 2024-09-03

sc 51089 and Bone Cancer

sc 51089 has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, W; Ma, N; Niu, JC; Wang, PJ	1

Other Studies

1 other study(ies) available for sc 51089 and Bone Cancer

Article	Year
EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth. Bosnian journal of basic medical sciences, 2019, Aug-20, Volume: 19, Issue:3 Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dinoprostone; Gene Silencing; Humans; Hydrazines; Mice; Mice, Nude; Osteosarcoma; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Xenograft Model Antitumor Assays	2019

Article

Year

EP1 receptor is involved in prostaglandin E2-induced osteosarcoma growth.

Bosnian journal of basic medical sciences, 2019, Aug-20, Volume: 19, Issue:3

Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dinoprostone; Gene Silencing; Humans; Hydrazines; Mice; Mice, Nude; Osteosarcoma; Oxazepines; Receptors, Prostaglandin E, EP1 Subtype; Xenograft Model Antitumor Assays

2019